TransMedics Group, a medical device company that provides a system for donor organ transport, raised $91 million by offering 5.7 million shares at $16, the midpoint of the $15 to $17 range. The company had originally filed to offer 4.7 million shares at the same range of $15-$17.
TransMedics Group plans to list on the Nasdaq under the symbol TMDX. Morgan Stanley and J.P. Morgan acted as lead managers on the deal.
Organ transport device maker TransMedics prices upsized IPO at $16 midpoint
May 1, 2019

